Mass Transport Modelling in support of leachable risk management

Mass Transport Modelling
Leachable risk management continues to be of regulatory interest. However, we continue to rely on experimental extractable studies as predictors of leachable risk. These are complex to design and implement and do not always offer the answer to what is the leachable risk for a drug product or medical device.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Creating a Circular Economy for the Pharmaceutical Packaging Industry

The pharma packaging sector is one of the most environmentally conscious segments of the overall pharma industry, driven in part by healthcare professionals and patients demonstrating.
Watch Now

Pharmaceutical Drug Development and BABE

Meetings International welcomes you to attend the "Webinar on Pharmaceutical Drug Development and BABE", on February 25, 2022.
Watch Now

Unlock the Power of Artificial Intelligence in Novel Drug Discovery

Discovering new “drug-like” and synthetically viable compounds via artificial intelligence (AI) is of great interest to medicinal chemists.
Watch Now

Applying Technology to New Science: Biopharma’s New Growth Engine

fiercepharma

Today, there are clear signs that the biopharmaceutical industry is facing a quiet yet potentially damaging force: compressive disruption. However, future-focused biopharma companies have found a way to deliver exceptional growth amidst compressive disruption: by embracing New Science, an ever-evolving combination of the best in science and health technology that is filling unmet need and raising the standard of care. Accenture research finds that leaders in New Science are investing 6-7x more in digital, data and genomics compared to their peers.
Watch Now

Spotlight

resources